<DOC>
	<DOCNO>NCT02389439</DOCNO>
	<brief_summary>This study prospective , single arm , open-labelled clinical trial . The total number subject 145 patient receive Pyronaridine-artesunate daily 3 day . Dosing accord body weight . All patient blood smear examine daily first week microscopy parasite clearance ( 2 consecutive negative slide two consecutive day ; asexual sexual stage ) . A negative blood slide define parasite count negative per 1000 WBC two consecutive day . The sample day 3 take close possible 72h initial blood smear . Participant follow 42 day assess drug efficacy safety ( Day 7 , 14 , 21 , 28 , 35 42 ) .</brief_summary>
	<brief_title>Efficacy Safety Pyronaridine-artesunate Treatment Uncomplicated Falciparum Malaria</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Pyronaridine</mesh_term>
	<criteria>Adults child ≥ 20 kg Symptomatic malaria infection , i.e . history fever within 24 hour and/or presence fever &gt; 37.5°c . Microscopic confirmation asexual stage P. falciparum ( P. falciparum mixed infection Pailin ) Capability take oral medication Written inform consent give participate trial Willingness ability adhere followup visit schedule Pregnancy lactation ( urine test β HCG perform woman child bearing age , 18 45 y/o ) Female age 1218y Parasitemia &gt; 150 000/µL ) . Signs symptom indicative severe malaria : Impaired consciousness ( Blantyre Coma Score &lt; 5 ) Severe anaemia ( Hct &lt; 15 % ) Bleeding disorder evidence epistaxis , bleed gum , frank haematuria , bleed venepuncture sit Respiratory distress Severe jaundice Known hypersensitivity artemisinins define history erythroderma/other severe cutaneous reaction , angioedema pyronaridine History splenectomy Known history evidence clinically significant disorder , : Known active Hepatitis A , e.g . detection anti HAVIgM . Known hepatitis B surface antigen ( HBsAg ) carrier . Known hepatitis C antibody ( HCV Ab ) . Liver function test ( AST/ALT level ) 2.5 time upper limit normal range .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>